It's time to think about LIFE, Cramer said Wednesday.
Life Technologies, that is.
The Carlsbad, Calif.-based company makes and sells instruments, consumables and services to biotechnology companies. Its products can be found in 90 percent of all research laboratories, Cramer said. Life also produces the raw ingredients needed to make biotech drugs.
Where did LIFE come from? It was formed two and a half years ago, Cramer said, when Invitrogen acquired Applied Biosystems for $4.6 billion. He likes this company because it benefits from a lot of recurring revenue with 80 percent of sales coming from consumables and services.
The stock spent most of the year languishing until it reported a better-than-expected quarter on Oct. 26. Since then, the it's been on a tear, but remains cheap being as it trades less than 14 times next year's earnings with a 11 percent long-term growth rate. To find out what LIFE has in store, watch Cramer's interview with CEO Greg Lucier.
Call Cramer: 1-800-743-CNBC
Questions for Cramer? madmoney@cnbc.com
Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com
